Clinical Trials Research and Development Sleep Terpenes 
MMJ Recs
DECEMBER 28, 2023
In this article, we’ll talk about a few of the most common conditions for which medical marijuana is prescribed, exploring the growing body of research and real-world experiences that contribute to its acceptance as a viable therapeutic option.
Greencamp
AUGUST 16, 2018
In this comprehensive guide, we are exploring the research on using cannabis for treating Amyotrophic lateral sclerosis (ALS)—a rare neuron disease that targets the motor neurons in the body. Exploring the available research on ALS and cannabinoids. As few as 10% of ALS patients live longer than 10 years after being diagnosed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Cannigma
JUNE 24, 2021
For instance when it comes to pain relief, THC and CBD have shown to be safer than opioids; and for anti-anxiety and sleep aids, CBD does not appear to be habit-forming like benzodiazepines. Getting a good night’s sleep is a crucial step in leading a healthier lifestyle, and the benefits can be felt throughout the day.
The Cannigma
DECEMBER 12, 2022
Now, psychedelic research is booming. And while most psychedelics are currently illegal in the United States and around the world, researchers are exploring their use in medicine to treat conditions such as depression, PTSD, addiction, anxiety, OCD, migraines, end of life acceptance of mortality, and eating disorders. 19 20 21 22 23.
CannaMD
AUGUST 8, 2020
Cannabinoids (natural and plant-derived) interact with endocannabinoid receptors to regulate appetite, sleep, pain, stress, and more. Researchers believe cannabis contains over 100 unique chemical compounds! Fortunately in 2014, the Federal Farm Bill re-opened the door for industrial hemp research. What makes CBD special?
The Cannigma
JUNE 15, 2021
Both THC and CBD were first isolated in a laboratory in the early 1940s by American researcher Roger Adams. It wasn’t until the 1960s, however, that Israeli researcher Raphael Mechoulam properly identified the chemical structure of CBD, which led to the wealth of knowledge and scope of research we have today. Shutterstock).
TheAnswerPage
JANUARY 11, 2022
Thus, an educational gap developed, creating a less than ideal situation for medical marijuana patients. So, why did this educational gap develop? the components of the cannabis plant (phytocannabinoids, terpenes, and flavonoids) and the health effects of cannabinoid-based therapy in the various patient populations.
Expert insights. Personalized for you.
98 
Let's personalize your content